Annual CFF
$49.20 M
-$163.38 M-76.86%
December 31, 2024
Summary
- As of March 10, 2025, VERV annual cash flow from financing activities is $49.20 million, with the most recent change of -$163.38 million (-76.86%) on December 31, 2024.
- During the last 3 years, VERV annual CFF has fallen by -$327.89 million (-86.95%).
- VERV annual CFF is now -86.95% below its all-time high of $377.09 million, reached on December 31, 2021.
Performance
VERV Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$25.15 M
+$25.14 M+179542.86%
December 1, 2024
Summary
- As of March 10, 2025, VERV quarterly cash flow from financing activities is $25.15 million, with the most recent change of +$25.14 million (+179542.86%) on December 1, 2024.
- Over the past year, VERV quarterly CFF has stayed the same.
- VERV quarterly CFF is now -91.28% below its all-time high of $288.41 million, reached on September 30, 2022.
Performance
VERV Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$49.20 M
-$152.23 M-75.58%
December 1, 2024
Summary
- As of March 10, 2025, VERV TTM cash flow from financing activities is $49.20 million, with the most recent change of -$152.23 million (-75.58%) on December 1, 2024.
- Over the past year, VERV TTM CFF has stayed the same.
- VERV TTM CFF is now -86.95% below its all-time high of $377.09 million, reached on December 31, 2021.
Performance
VERV TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VERV Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -76.9% | 0.0% | 0.0% |
| 3 y3 years | -87.0% | -21.2% | -34.2% |
| 5 y5 years | +174.0% | -21.2% | -34.2% |
VERV Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -87.0% | at low | -91.3% | >+9999.0% | -87.0% | +3664.0% |
| 5 y | 5-year | -87.0% | +174.0% | -91.3% | +3000.8% | -87.0% | +3664.0% |
| alltime | all time | -87.0% | +174.0% | -91.3% | +3000.8% | -87.0% | +3664.0% |
Verve Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $49.20 M(-76.9%) | - | - |
| Dec 2024 | - | $25.15 M(>+9900.0%) | $49.20 M(-75.6%) |
| Sep 2024 | - | $14.00 K(-98.9%) | $201.43 M(-13.7%) |
| Jun 2024 | - | $1.30 M(-94.3%) | $233.34 M(+0.0%) |
| Mar 2024 | - | $22.73 M(-87.2%) | $233.27 M(+9.7%) |
| Dec 2023 | $212.58 M(-35.4%) | $177.38 M(+455.7%) | $212.58 M(+184.2%) |
| Sep 2023 | - | $31.92 M(+2489.1%) | $74.79 M(-77.4%) |
| Jun 2023 | - | $1.23 M(-39.5%) | $331.28 M(+0.2%) |
| Mar 2023 | - | $2.04 M(-94.9%) | $330.49 M(+0.5%) |
| Dec 2022 | $328.96 M | $39.60 M(-86.3%) | $328.96 M(+13.2%) |
| Sep 2022 | - | $288.41 M(>+9900.0%) | $290.58 M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $445.00 K(-11.9%) | $1.31 M(-99.5%) |
| Mar 2022 | - | $505.00 K(-58.7%) | $283.76 M(-24.7%) |
| Dec 2021 | $377.09 M(+307.1%) | $1.22 M(-241.2%) | $377.09 M(+0.3%) |
| Sep 2021 | - | -$867.00 K(-100.3%) | $375.87 M(-0.2%) |
| Jun 2021 | - | $282.90 M(+201.5%) | $376.74 M(+140.4%) |
| Mar 2021 | - | $93.83 M(>+9900.0%) | $156.73 M(+69.2%) |
| Dec 2020 | $92.63 M(+415.9%) | - | - |
| Dec 2020 | - | $8000.00(>+9900.0%) | $92.63 M(+0.0%) |
| Sep 2020 | - | $0.00(-100.0%) | $92.62 M(0.0%) |
| Jun 2020 | - | $62.89 M(+111.5%) | $92.62 M(+211.5%) |
| Mar 2020 | - | $29.73 M | $29.73 M |
| Dec 2019 | $17.95 M | - | - |
FAQ
- What is Verve Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Verve Therapeutics?
- What is Verve Therapeutics annual CFF year-on-year change?
- What is Verve Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Verve Therapeutics?
- What is Verve Therapeutics quarterly CFF year-on-year change?
- What is Verve Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Verve Therapeutics?
- What is Verve Therapeutics TTM CFF year-on-year change?
What is Verve Therapeutics annual cash flow from financing activities?
The current annual CFF of VERV is $49.20 M
What is the all time high annual CFF for Verve Therapeutics?
Verve Therapeutics all-time high annual cash flow from financing activities is $377.09 M
What is Verve Therapeutics annual CFF year-on-year change?
Over the past year, VERV annual cash flow from financing activities has changed by -$163.38 M (-76.86%)
What is Verve Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of VERV is $25.15 M
What is the all time high quarterly CFF for Verve Therapeutics?
Verve Therapeutics all-time high quarterly cash flow from financing activities is $288.41 M
What is Verve Therapeutics quarterly CFF year-on-year change?
Over the past year, VERV quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Verve Therapeutics TTM cash flow from financing activities?
The current TTM CFF of VERV is $49.20 M
What is the all time high TTM CFF for Verve Therapeutics?
Verve Therapeutics all-time high TTM cash flow from financing activities is $377.09 M
What is Verve Therapeutics TTM CFF year-on-year change?
Over the past year, VERV TTM cash flow from financing activities has changed by $0.00 (0.00%)